Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, provided an update on its ongoing regulatory compliance and initial deployment activities for its telehealth platform in Venezuela. The company is advancing early-stage deployment, testing, and refinement of the platform, which is accessible through its digital interface at https://latamedai.org. Current efforts involve evaluating system performance, user workflows, and operational capabilities as part of the initial launch.
The telehealth platform is designed to support remote patient engagement, care coordination, and the integration of AI-driven healthcare analytics tools. The company is focusing on enhancing platform functionality, improving data integration, and optimizing the user experience. In parallel, Catalyst Crew is working with the Ministerio del Poder Popular para la Salud, including the Servicio Autónomo de Contraloría Sanitaria (SACS), to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital. The company is progressing through the regulatory process, coordinating with authorities on documentation, operational procedures, and compliance standards.
Management anticipates that the permitting process may be completed in the near term, though no assurance can be given on the timing or outcome. The company believes this phase of deployment, testing, and regulatory alignment is a crucial step toward broader operational rollout across its target markets. Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated: "Our focus is on building a scalable telehealth platform that can operate effectively within real-world healthcare environments. We are currently advancing platform testing, refinement, and regulatory alignment as we continue to build the foundation for broader deployment across Latin America. We expect a full launch in short order and upon receiving all regulatory approvals."
The company continues to advance its digital health and AI platform, including telehealth infrastructure and AI-driven healthcare analytics capabilities. More information is available at https://catalystcrewai.com or in the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
